Health Care: Drugs

Bioline Rx Ltd (BLRX: NASDAQ)

$1.33 -0.03 | -2.21%
10/22/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011
Sales 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00
Selling, General, and Administrative Expenses 4.88M 4.62M 4.21M
Research & Development 12.65M 17.21M 11.20M
Operating Income before D & A (EBITDA) -17.53M -21.83M -15.41M
Depreciation & Amortization 329.36K 407.93K 410.67K
Interest Income 746.59K 2.36M 3.34M
Other Income - Net 1.20M 1.06M 0.00
Special Income / Charges 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -15.91M -18.82M -12.48M
Interest Expense 1.97M 2.00M 1.12M
Pre-Tax Income -17.88M -20.82M -13.60M
Income Taxes 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -17.64M -20.42M -13.19M
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -17.64M -20.42M -13.19M
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -17.64M -20.42M -13.19M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-17.64M -20.42M -13.19M
Preferred Dividends
Net Income Available To Common -17.64M -20.42M -13.19M
Basic EPS from Continuing Ops. -0.78 -1.21 -1.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -0.78 -1.21 -1.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.01 0.00 -0.01
Basic EPS, Total -0.78 -1.20 -1.08
Basic Normalized Net Income/Share -0.78 -1.21 -1.07
EPS fr Continuing Ops. -0.78 -1.21 -1.07
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -0.78 -1.21 -1.07
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) 0.01 0.00 -0.01
EPS, Total -0.78 -1.20 -1.08
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.78 -1.21 -1.07
Dividends Paid per Share 0.00 0.00 0.00

Portfolios with BLRX

Latest BLRX Headlines from TheStreet

More Financial News for BLRX

Press Releases for BLRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter